FDA — authorised 27 September 2018
- Marketing authorisation holder: PFIZER INC
- Status: approved
🇺🇸 Vizimpro in United States
FDA authorised Vizimpro on 27 September 2018
Marketing authorisations
FDA — authorised 27 September 2018
- Application: NDA211288
- Marketing authorisation holder: PFIZER
- Indication: Type 1 - New Molecular Entity
- Status: approved
Vizimpro in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Vizimpro approved in United States?
Yes. FDA authorised it on 27 September 2018; FDA authorised it on 27 September 2018.
Who is the marketing authorisation holder for Vizimpro in United States?
PFIZER INC holds the US marketing authorisation.